614 related articles for article (PubMed ID: 9211017)
1. Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure.
Ruffolo RR; Feuerstein GZ
Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():247-56. PubMed ID: 9211017
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection.
Feuerstein GZ; Ruffolo RR
Eur Heart J; 1996 Apr; 17 Suppl B():24-9. PubMed ID: 8733068
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of carvedilol in the myocardium.
Feuerstein GZ; Bril A; Ruffolo RR
Am J Cardiol; 1997 Dec; 80(11A):41L-45L. PubMed ID: 9412541
[TBL] [Abstract][Full Text] [Related]
4. Vasodilatory action of carvedilol.
Sponer G; Strein K; Bartsch W; Müller-Beckmann B
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S5-11. PubMed ID: 1378150
[TBL] [Abstract][Full Text] [Related]
5. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
[TBL] [Abstract][Full Text] [Related]
6. Myocardial protection with carvedilol.
Feuerstein GZ; Hamburger SA; Smith EF; Bril A; Ruffolo RR
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S138-41. PubMed ID: 1378142
[TBL] [Abstract][Full Text] [Related]
7. Recent observations with beta-adrenoceptor blockade. Beneficial effects in hypertension and heart failure.
Ruffolo RR; Feuerstein GZ; Ohlstein EH
Am J Hypertens; 1998 Jan; 11(1 Pt 2):9S-14S. PubMed ID: 9503101
[TBL] [Abstract][Full Text] [Related]
8. Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential.
Cheng J; Kamiya K; Kodama I
Cardiovasc Drug Rev; 2001; 19(2):152-71. PubMed ID: 11484068
[TBL] [Abstract][Full Text] [Related]
9. Beta-blockers in congestive heart failure: the pharmacology of carvedilol, a vasodilating beta-blocker and antioxidant, and its therapeutic utility in congestive heart failure.
Feuerstein G; Ruffolo RR
Adv Pharmacol; 1998; 42():611-5. PubMed ID: 9327976
[No Abstract] [Full Text] [Related]
10. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection.
Feuerstein GZ; Ruffolo RR
Eur Heart J; 1995 Jul; 16 Suppl F():38-42. PubMed ID: 8521883
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol: something else than a simple betablocker?
Palazzuoli A; Calabria P; Verzuri MS; Auteri A
Eur Rev Med Pharmacol Sci; 2002; 6(6):115-26. PubMed ID: 12776805
[TBL] [Abstract][Full Text] [Related]
12. Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol.
Feuerstein G; Yue TL; Ma X; Ruffolo RR
Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):17-24. PubMed ID: 9715819
[TBL] [Abstract][Full Text] [Related]
13. Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure.
Ruffolo RR; Feuerstein GZ
J Cardiovasc Pharmacol; 1998; 32 Suppl 1():S22-30. PubMed ID: 9731692
[TBL] [Abstract][Full Text] [Related]
14. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure.
DasGupta P; Broadhurst P; Lahiri A
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S12-6. PubMed ID: 1721973
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF
Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
[TBL] [Abstract][Full Text] [Related]
16. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
McTavish D; Campoli-Richards D; Sorkin EM
Drugs; 1993 Feb; 45(2):232-58. PubMed ID: 7681374
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic profile of carvedilol.
van Zwieten PA
Cardiology; 1993; 82 Suppl 3():19-23. PubMed ID: 8106159
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.
Dunn CJ; Lea AP; Wagstaff AJ
Drugs; 1997 Jul; 54(1):161-85. PubMed ID: 9211087
[TBL] [Abstract][Full Text] [Related]
19. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
[TBL] [Abstract][Full Text] [Related]
20. Preclinical and clinical pharmacology of carvedilol.
Ruffolo RR; Boyle DA; Venuti RP; Lukas MA
J Hum Hypertens; 1993 Feb; 7 Suppl 1():S2-15. PubMed ID: 8487245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
